Armata Pharmaceuticals, Inc.
ARMP- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000921114
No open-market purchases or sales by Armata Pharmaceuticals, Inc. insiders were filed in the last 90 days; 53 institutions reported holding it in 13F filings for Q2 2026, worth $32.3M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Armata Pharmaceuticals, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- 0 vs. Q1 2023
- Shares held
- 1.19M
- −49.0K (−4.0%) vs. Q1 2023
- Total value
- $1.35M
- −$711.2K (−34.5%) vs. Q1 2023
- New holders
- 2
- 3 more added
- Sold out
- 2
- 5 more reduced
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARMP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 53 | $32.3M |
| Q1 2026 | 45 | $40.2M |
| Q4 2025 | 36 | $7.85M |
| Q3 2025 | 28 | $2.27M |
| Q2 2025 | 29 | $1.40M |
| Q1 2025 | 26 | $1.08M |
| Q4 2024 | 24 | $2.57M |
| Q3 2024 | 24 | $3.28M |
| Q2 2024 | 23 | $3.86M |
| Q1 2024 | 24 | $5.94M |
| Q4 2023 | 25 | $4.17M |
| Q3 2023 | 23 | $3.85M |
| Q2 2023 | 22 | $1.35M |
| Q1 2023 | 23 | $2.06M |
| Q4 2022 | 26 | $1.61M |
| Q3 2022 | 20 | $5.73M |
| Q2 2022 | 19 | $5.25M |
| Q1 2022 | 20 | $6.61M |
| Q4 2021 | 17 | $7.31M |
| Q3 2021 | 20 | $4.32M |
| Q2 2021 | 21 | $4.59M |
| Q1 2021 | 23 | $5.62M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Armata Pharmaceuticals, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 634,444 | $723.3K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 193,682 | $220.8K | 0.01% | 00.0% | Unchanged |
| Edgewood Management LLC | 100,000 | $114.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 62,396 | $71.0K | 0.00% | −800−1.3% | Reduced |
| Vanguard Group Inc | 59,890 | $68.3K | 0.00% | +2,708+4.7% | Added |
| BlackRock Inc. | 24,416 | $27.8K | 0.00% | −952−3.8% | Reduced |
| Geode Capital Management, LLC | 22,463 | $25.6K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 19,380 | $22.1K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 19,742 | $22.0K | 0.00% | −11,452−36.7% | Reduced |
| SeaCrest Wealth Management, LLC | 18,130 | $20.7K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 13,548 | $15.4K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 11,472 | $13.1K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,234 | $4.83K | 0.00% | +1,091+34.7% | Added |
| Trifecta Capital Advisors, LLC | 714 | $814 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 571 | $651 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 148 | $169 | 0.00% | +148 | New |
| Salem Investment Counselors Inc | 100 | $114 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 79 | $90 | 0.00% | +4+5.3% | Added |
| Morgan Stanley | 2 | $2 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1 | $1 | 0.00% | −4,001−100.0% | Reduced |
| Simplex Trading, LLC | 103 | $0 | 0.00% | −97−48.5% | Reduced |
| Royal Bank of Canada | 18 | $0 | 0.00% | +18 | New |
| Ergoteles LLC | 0 | $0 | 0.00% | −24,585−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −11,130−100.0% | Sold out |
| Householder Group Estate & Retirement Specialist, LLC | – | – | – | – | Not filed |